Cedars-Sinai Cancer appoints melanoma research director

Bin Zheng, PhD, who specializes in targeted therapies and immunotherapy, was appointed director of melanoma research in the Department of Biomedical Sciences at Los Angeles-based Cedars-Sinai Cancer.

In his new role, Dr. Zheng will be tasked with developing and leading a comprehensive translational and basic science research program for melanoma by working closely with the organization's surgical and medical oncology leadership team, according to an April 16 news release from Cedars-Sinai.

Dr. Zheng's research focuses on how the metabolism of melanoma cancer cells and the tumor microenvironment influence resistance mechanisms to existing immunotherapies, such as checkpoint inhibitors, which fight cancer with a patient's immune system.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars